| Company Name: |
Hangzhou Peptidego Biotech Co.,Ltd.
|
| Tel: |
0571-87213919 |
| Email: |
Eric@peptidego.com |
| Products Intro: |
Product Name:Ac-Leu-Leu-Leu-Leu-Arg-Val-Lys-Arg-NH2
CAS:1413058-07-7
Purity:95% or 98% HPLC Package:1mg；5mg；10mg；50mg；100mg,1g or according to customer's detail requirement.
|
|
| | Multi-Leu peptide Basic information |
| Product Name: | Multi-Leu peptide | | Synonyms: | Multi-Leu peptide;L-Argininamide, N-acetyl-L-leucyl-L-leucyl-L-leucyl-L-leucyl-L-arginyl-L-valyl-L-lysyl-;Ac-Leu-Leu-Leu-Leu-Arg-Val-Lys-Arg-NH2 | | CAS: | 1413058-07-7 | | MF: | C49H94N16O9 | | MW: | 1051.37 | | EINECS: | | | Product Categories: | | | Mol File: | 1413058-07-7.mol |  |
| | Multi-Leu peptide Chemical Properties |
| density | 1.29±0.1 g/cm3(Temp: 20 °C; Press: 760 Torr)(predicted) | | pka | 13.35±0.46(predicted) |
| | Multi-Leu peptide Usage And Synthesis |
| Uses | Multi-Leu peptide (ML-peptide) is a potent inhibitor of PACE4 (Ki=22 nM). Multi-Leu peptide can competitively bind to the active site of PACE4 by simulating the substrate sequence of PACE4, thereby inhibiting its catalytic activity. Multi-Leu peptide can be used to study the specific mechanism of PACE4 in the development of prostate cancer[1]. | | References | [1] ?epek T, et al. Macrocyclization of a potent PACE4 inhibitor: Benefits and limitations[J]. European journal of cell biology, 2017, 96(5): 476-485. DOI:10.1016/j.ejcb.2017.04.001 |
| | Multi-Leu peptide Preparation Products And Raw materials |
|